Drug of choice for treatment of malignant hyperthermia –
**Core Concept**
Malignant hyperthermia (MH) is a life-threatening medical emergency that occurs in response to certain anesthetic agents, characterized by a hypermetabolic state, muscle rigidity, and elevated body temperature. The condition is caused by an abnormality in the ryanodine receptor (RyR1) gene, leading to an excessive release of calcium ions from the sarcoplasmic reticulum.
**Why the Correct Answer is Right**
The treatment of malignant hyperthermia involves immediate cessation of the triggering anesthetic agent, administration of specific medications to control the hypermetabolic state, and supportive care to manage complications. Dantrolene is the drug of choice for treating malignant hyperthermia, as it acts by inhibiting the release of calcium ions from the sarcoplasmic reticulum through its action on the RyR1 receptor. Dantrolene's mechanism of action is distinct from other muscle relaxants, making it the preferred treatment for MH.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not specify a medication proven to treat malignant hyperthermia. While some medications may be used to manage symptoms, they are not the primary treatment for MH.
**Option B:** This option is incorrect as it is a medication used to treat other conditions, such as hypertension and asthma, but is not the drug of choice for malignant hyperthermia.
**Option C:** This option is incorrect as it is a medication used to treat other conditions, such as Parkinson's disease, but is not the primary treatment for malignant hyperthermia.
**Clinical Pearl / High-Yield Fact**
Dantrolene is a critical medication in the treatment of malignant hyperthermia, and its administration should be initiated promptly in suspected cases. A key aspect of dantrolene's mechanism of action is its ability to inhibit the release of calcium ions from the sarcoplasmic reticulum, which helps to control the hypermetabolic state associated with MH.
**Correct Answer:** D. Dantrolene